These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7435113)

  • 21. Galactrorrhoea, hyperprolactinaemia and pituitary tumours in the female.
    Nader S; Mashiter K; Doyle FH; Joplin GF
    Clin Endocrinol (Oxf); 1976 May; 5(3):245-51. PubMed ID: 954219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galactorrhoea-amenorrhoea and hyperprolactinaemia: pathophysiological aspects and diagnostic tests.
    Tolis G
    Clin Endocrinol (Oxf); 1977; 6 Suppl():81S-89S. PubMed ID: 568528
    [No Abstract]   [Full Text] [Related]  

  • 23. Hyperprolactinaemic amenorrhoea in Hong Kong.
    Tang LC; Sung ML; Ma HK
    Aust N Z J Obstet Gynaecol; 1983 Aug; 23(3):165-9. PubMed ID: 6580885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia.
    Massara F; Camanni F; Martra M; Dolfin GC; Müller EE; Molinatti GM
    Clin Endocrinol (Oxf); 1983 Feb; 18(2):103-10. PubMed ID: 6851194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The natural history of idiopathic hyperprolactinemia.
    Martin TL; Kim M; Malarkey WB
    J Clin Endocrinol Metab; 1985 May; 60(5):855-8. PubMed ID: 3980670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and significance of hyperprolactinaemia in women with amenorrhea.
    Franks S; Murray MA; Jequier AM; Steele SJ; Nabarro JD; Jacobs HS
    Clin Endocrinol (Oxf); 1975 Nov; 4(6):597-607. PubMed ID: 1104218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma prolactin-releasing factor-like activity in the amenorrhea-galactorrhea syndrome.
    Garthwaite TL; Hagen TC
    J Clin Endocrinol Metab; 1978 Oct; 47(4):885-8. PubMed ID: 122415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoreactive prolactin in breast milk and plasma of women with hyperprolactinemia, galactorrhea and menstrual dysfunction.
    Yuen BH
    Int J Fertil; 1986; 31(1):67-70. PubMed ID: 2908279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prolactinemia and ovarian function regulation disorders. I. Amenorrhea-galactorrhea].
    Pérez Peña E; Cabeza de Flores A; Flores Lozano F
    Ginecol Obstet Mex; 1980 Aug; 48(286):69-75. PubMed ID: 7192673
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hyperprolactinemia--its relation to galactorrhea, amenorrhea, pituitary tumor and its management].
    Ge QS
    Zhonghua Yi Xue Za Zhi; 1984 Sep; 64(9):545-9. PubMed ID: 6442615
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of sulpiride induced hyperprolactinaemia in patients with Turner's syndrome.
    Loli P; Riolo A; Bonomo M; Ronzoni M; Botalla L; Gelli D
    Clin Endocrinol (Oxf); 1980 Jul; 13(1):9-16. PubMed ID: 6777091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bromocryptine therapy in cases of amenorrhea-galactorrhea.
    Mroueh AM; Siler-Khodr TM
    Am J Obstet Gynecol; 1977 Feb; 127(3):291-8. PubMed ID: 576372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variation of serum prolactin-releasing activity in women with the galactorrhea-amenorrhea syndrome after bromocriptine treatment.
    Takahashi K; Minato K; Ikeno N; Watanabe M; Endo H; Yamamoto H
    Am J Obstet Gynecol; 1983 May; 146(1):74-9. PubMed ID: 6405619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on galactorrhea-amenorrhea syndrome (GAS) with special reference to normoprolactinemic GAS].
    Imai T; Yasuda K; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1988 Jan; 64(1):1-15. PubMed ID: 3132404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperprolactinemia, amenorrhea, and galactorrhea. A retrospective assessment of twenty-five cases.
    Koppelman MC; Jaffe MJ; Rieth KG; Caruso RC; Loriaux DL
    Ann Intern Med; 1984 Jan; 100(1):115-21. PubMed ID: 6537879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hyperprolactinemia in relation to galactorrhea and amenorrhea].
    Zhang LZ
    Zhonghua Fu Chan Ke Za Zhi; 1983 Oct; 18(4):218-21. PubMed ID: 6426895
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
    Seki K; Seki M; Okumura T
    Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galactorrhoea, amenorrhoea and hyperprolactinaemia after an operation on the breast: A case report.
    Sandler MP; Forman MB; Lopis R; Kalk WJ
    S Afr Med J; 1980 Jan; 57(3):95-6. PubMed ID: 7190737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A clinical study on the characteristics of galactorrhea-amenorrhea (especially of drug-induced galactorrhea-amenorrhea].
    Onda H
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1851-60. PubMed ID: 6438254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Twenty-four-hour prolactin secretory patterns in women with galactorrhea, normal menses, normal random prolacting levels and abnormal sellar tomograms.
    Kapcala LP; Molitch ME; Arno J; King LW; Reichlin S; Wolpert SM
    J Endocrinol Invest; 1984 Oct; 7(5):455-60. PubMed ID: 6439770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.